## Preclinical products

1. [Simcyp PBPK provides physiologically based pharmacokinetic modeling to predict drug behavior in diverse populations.](https://www.certara.com/software/simcyp-pbpk/)
2. [Innovative PBPK software that supports screening, first-in-human dose prediction, early DDI and formulation decisions.](https://www.certara.com/simcyp/discovery/)
3. [Predict and analyze off-target risks in drug development for safer outcomes.](https://www.certara.com/toxstudio/secondary-intelligence/)
4. [Simcyp Biopharmaceutics software is an advanced PBPK platform for biopharmaceutics, formulation, and CMC experts.](https://www.certara.com/software/simcyp-biopharmaceutics/)
5. [Certara IQ is an AI-enabled QSP modeling software that scales quantitative systems pharmacology, offering validated models, workflows, and regulatory-ready insights.](https://www.certara.com/software/quantitative-systems-pharmacology/)
6. [A validated, web-based application to provide advanced viewing, data summarization, and visualization capabilities for study non-clinical data produced in SEND format.](https://www.certara.com/send-explorer-software/)

## Preclinical services

1. [Streamline first-in-human studies with physiologically based modeling to optimize dosing and reduce trial risks.](https://www.certara.com/first-in-human-fih-dose-prediction/)
2. [Expert nonclinical drug development consulting services, from hit to lead identification, into first-in-human studies and regulatory strategy.](https://www.certara.com/services/nonclinical-development-science-services/)
3. [Certara’s expert CMC consultants provide CMC support across all phases of drug development, from early preclinical development to post-market activities.](https://www.certara.com/services/early-development/chemistry-manufacturing-and-controls-cmc-services/)
4. [Our Toxicology Consultants provide core professional nonclinical safety services consulting, to help support your product through regulatory stages.](https://www.certara.com/services/early-development/toxicology-services-and-nonclinical-drug-development-support/)
5. [Strategic guidance and end-to-end support to navigate global regulatory pathways, ensuring efficient and compliant drug development from preclinical stages through market approval.](https://www.certara.com/services/early-development/regulatory-affairs-consulting/)